BlackRock’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.02M | Sell |
1,741,747
-2,487,750
| -59% | -$2.89M | ﹤0.01% | 3984 |
|
|
2025
Q1 | $6.72M | Sell |
4,229,497
-8,592
| -0.2% | -$13.7K | ﹤0.01% | 3469 |
|
|
2024
Q4 | $12.8M | Sell |
4,238,089
-523,084
| -11% | -$1.58M | ﹤0.01% | 3250 |
|
|
2024
Q3 | $17.5M | Sell |
4,761,173
-57,373
| -1% | -$211K | ﹤0.01% | 3080 |
|
|
2024
Q2 | $19.7M | Buy |
4,818,546
+172,788
| +4% | +$707K | ﹤0.01% | 2950 |
|
|
2024
Q1 | $73.2M | Sell |
4,645,758
-39,217
| -0.8% | -$618K | ﹤0.01% | 2207 |
|
|
2023
Q4 | $71M | Buy |
4,684,975
+289,118
| +7% | +$4.38M | ﹤0.01% | 2244 |
|
|
2023
Q3 | $88.2M | Buy |
4,395,857
+445,053
| +11% | +$8.93M | ﹤0.01% | 2038 |
|
|
2023
Q2 | $111M | Buy |
3,950,804
+533,337
| +16% | +$15M | ﹤0.01% | 1955 |
|
|
2023
Q1 | $58.8M | Sell |
3,417,467
-54,712
| -2% | -$941K | ﹤0.01% | 2305 |
|
|
2022
Q4 | $69.9M | Buy |
3,472,179
+136,113
| +4% | +$2.74M | ﹤0.01% | 2221 |
|
|
2022
Q3 | $72.3M | Buy |
3,336,066
+95,008
| +3% | +$2.06M | ﹤0.01% | 2150 |
|
|
2022
Q2 | $91.1M | Buy |
3,241,058
+398,478
| +14% | +$11.2M | ﹤0.01% | 2055 |
|
|
2022
Q1 | $131M | Sell |
2,842,580
-365
| -0% | -$16.8K | ﹤0.01% | 1936 |
|
|
2021
Q4 | $239M | Buy |
2,842,945
+87,157
| +3% | +$7.33M | 0.01% | 1596 |
|
|
2021
Q3 | $184M | Buy |
2,755,788
+435,672
| +19% | +$29M | 0.01% | 1764 |
|
|
2021
Q2 | $123M | Buy |
2,320,116
+43,343
| +2% | +$2.31M | ﹤0.01% | 2105 |
|
|
2021
Q1 | $98.8M | Buy |
2,276,773
+1,624
| +0.1% | +$70.5K | ﹤0.01% | 2185 |
|
|
2020
Q4 | $118M | Buy |
2,275,149
+1,315,141
| +137% | +$68.3M | ﹤0.01% | 1960 |
|
|
2020
Q3 | $31.4M | Buy |
960,008
+47,459
| +5% | +$1.55M | ﹤0.01% | 2526 |
|
|
2020
Q2 | $43.8M | Buy |
+912,549
| New | +$43.8M | ﹤0.01% | 2299 |
|